Kaleb H. Yohay - Publications

"It's not any one thing, it's always all of them, all at the same time": quality of life in NF2-related schwannomatosis from patient and clinician perspectives.

Journal: Familial cancer

Published: July 14, 2025

Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas.

Journal: Neuro-oncology advances

Published: June 27, 2025

The Association Between Age and Outcomes of Bevacizumab Treatment in NF2-Related Schwannomatosis.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: April 21, 2025

Cognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force.

Journal: Genes & development

Published: March 24, 2025

Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey.

Journal: Orphanet journal of rare diseases

Published: November 06, 2024

Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.

Journal: The New England journal of medicine

Published: June 21, 2024

Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib.

Journal: Pediatric dermatology

Published: February 20, 2024

Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1.

Journal: Pediatric neurology

Published: January 13, 2024

Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 16, 2022

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.

Journal: Neuro-oncology

Published: July 05, 2022

Management of neurofibromatosis type 1-associated plexiform neurofibromas.

Journal: Neuro-oncology

Published: June 03, 2022

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: May 10, 2022